Emily Lee Kelley

Nessuna posizione attualmente

66 anni

Health Technology

Commercial Services

Consumer Services

Profilo

Ms. Emily L.
Kelley is Vice President-Human Resources at Alexza Pharmaceuticals, Inc. Ms. Kelley was previously employed as VP-Human Resources, Finance & Operations by Affymax Research Institute.
She received her undergraduate degree from the University of California, Berkeley.

Precedenti posizioni note di Emily Lee Kelley

Società	Posizione	Fine
Affymax Research Institute Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001.	Director of Finance/CFO	01/01/2001
ALEXZA PHARMACEUTICALS, INC.	Human Resources Officer	-

Vedi nel dettaglio l'esperienza di Emily Lee Kelley

Formazione di Emily Lee Kelley

University of California, Berkeley

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Emily Lee Kelley

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Alexza Pharmaceuticals, Inc. Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.	Health Technology
Affymax Research Institute Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001.	Commercial Services